The Silent Epidemic: Why Diabetic Foot Ulcers Have Been Overlooked for Three Decades
Chronic wounds demand clinicians willing to act outside of their defined role, not because the system incentivizes it, but because without it, the wound will not heal.
Reading the Body’s Signals: AI’s Ultimate Healthcare Opportunity
We are on the cusp of an age of anticipatory medicine, an explosion in our ability to read the body's signals and catch the killers before they do their damage.
AstraZeneca, Amgen Drug Moves Closer to Competing With Dupixent in a New Indication
AstraZeneca and Amgen drug Tezspire met the goals of a Phase 3 test in eosinophilic esophagitis (EoE), a chronic disorder whose only approved biologic therapy is Sanofi’s Dupixent. An approval for Tezspire in EoE would be its third indication, bolstering sales of the blockbuster product.
Datavant’s New Platform Could Cut Record Retrieval Time from Days to Hours
Datavant launched a new provider exchange platform, which replaces fax-based record requests with a digital workflow. It aims to give care teams real-time visibility into request status while easing the administrative burden on clinical staff.
Precision Medicine Transformed Oncology —It’s Time to Do the Same for Sepsis
It’s time we reignite treatment development for sepsis and other immune-mediated conditions that strike when patients are most vulnerable.